Coronavirus antibody tests have garnered attention from officials as a potential tool to evaluate people’s immunity to the illness. But the majority of companies creating the tests have had little to no regulatory oversight, according to the chair of the House Subcommittee on Economic and Consumer Policy.
Antibody tests, when accurate, can detect if someone has been exposed to the coronavirus in the past. More than 100 of these tests have been brought to market in the last several weeks, but the majority of them are not being tested by the Food and Drug Administration, said Raja Krishnamoorthi (D-Ill.) in an interview on Sunday with NPR’s Weekend Edition.
Krishnamoorthi said that federal officials have told his subcommittee that companies selling antibody tests can go one of two routes as they seek to bring their products to market.